ClinicalTrials.gg
Active, not recruitingNCT04698590WFG ScleralsUpdated May 3, 2024

Wavefront Guided Scleral Lenses for Keratoconus and Irregular Astigmatism

An interventional study of Wavefront Guided Scleral Lenses and Traditional Scleral Lenses in Keratoconus, Irregular Astigmatism and Corneal Ectasia, sponsored by Cornea and Laser Eye Institute. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-03.

Sponsored by Cornea and Laser Eye Institute · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 9 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Aberrations are the spreading of light from a point focus. Aberrations of the eyes can be objectively evaluated with a wavefront aberrometer. Lower order aberrations such as defocus and astigmatism can be corrected with glasses and traditional/disposable soft contact lenses. Patients with ectatic corneal disease, such as keratoconus, or irregular astigmatism cause by surgery, trauma or disease, experience vision that is unlikely to be adequately corrected with glasses or disposable soft contact lenses due to higher order aberrations (HOA). HOA's cause halos, flare, glare, starbursts, doubling, smearing or ghosting of vision. Specialty contact lenses, such as scleral lenses, can be used to mask the irregularity of the cornea, reducing HOA's and improving vision. In many patients the resultant vision, though improved, still has some level of residual HOA's affecting the quality of vision. Custom scleral lenses with customized wavefront guided optics can be used to reduce residual HOA's and improve vision further. These lenses have been referred to as higher order aberration correcting scleral lenses or HOA correcting sclerals and wavefront guided scleral lenses or WFG sclerals.

Read the detailed description

The purpose of this study is to investigate the effect of an advanced technique for designing custom scleral contact lenses to further improve vision in keratoconus or irregular astigmatism by reducing residual aberrations. The derived custom scleral lenses will include customized aberration correcting optics, guided by a wavefront aberrometer measurements. These lenses are custom made based on the individual measurements from an eye.The primary objective of this study is to evaluate the vision differences between traditional scleral lens optics and customized scleral lens optics. In particular, the investigators will compare efficacy in reducing aberrations and improvement in vision.

02

Conditions studied

  • Keratoconus
  • Irregular Astigmatism
  • Corneal Ectasia
  • Aberration, Corneal Wavefront
  • Wavefront Aberration, Corneal
  • Pellucid Marginal Corneal Degeneration
  • Keratoglobus

Browse trials for

Keywords

  • Scleral lenses
  • Scleral lens
  • Wavefront guided scleral lenses
  • Higher order aberrations
  • HOA scleral lenses
  • Sclerals
  • Higher order aberration correction
  • Custom scleral lenses
  • Wavefront guided
  • Keratoconus
  • Irregular Astigmatism
  • WFG scleral lenses
03

In context

Keratoconus

313 studies on the registry are indexed under Keratoconus; 56 are open to participants now.

This study's planned enrollment of 100 is above the median of 40 across 205 interventional studies indexed under Keratoconus.

Browse Keratoconus studies →

Lead sponsor

Cornea and Laser Eye Institute is the lead sponsor of 10 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

-A diagnosis of keratoconus or irregular astigmatism

Exclusion criteria

Exclusion Criteria:

  • Patients with other visually significant ocular pathology.
  • Inability to apply or remove a scleral lens.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    WFG Scleral Lenses

    Scleral lenses with customized wavefront guided optics

    Device: Wavefront Guided Scleral Lenses

  • Placebo comparator
    Traditional Scleral Lenses

    Scleral lenses with traditional optics

    Device: Traditional Scleral Lenses

Interventions

  • DeviceWavefront Guided Scleral Lenses

    Custom wavefront guided, higher order aberration correcting scleral lenses

    Also known as: ARES Scleral Lenses

  • DeviceTraditional Scleral Lenses

    Traditional scleral lenses

    Also known as: CS Scleral Lenses

06

What researchers measure

Primary outcomes

  1. Higher order aberration

    Total higher order aberrations with traditional scleral lenses will be compared with wavefront guided scleral lenses for all eyes. A secondary analysis of this endpoint, the change in total higher order aberrations with wavefront guided scleral lenses from dispense to 4 week follow up, will be evaluated.

    Time frame: 4 weeks

Secondary outcomes

  1. Visual Acuity

    Visual acuity with traditional scleral lenses will be compared to visual acuity with wavefront guided scleral lenses for all eyes. A secondary analysis of this endpoint, the change in visual acuity from dispense to 4 week follow up, will be evaluated for signs of neural adaptation.

    Time frame: 4 weeks

  2. Contrast Sensitivity

    Contrast sensitivity with traditional scleral lenses will be compared to contrast sensitivity with wavefront guided scleral lenses for all eyes. A secondary analysis of this endpoint, the change in contrast sensitivity with wavefront guided scleral lenses from dispense to 4 week follow up, will be evaluated for signs of neural adaptation.

    Time frame: 4 weeks

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04698590
Lead sponsor
Cornea and Laser Eye Institute
Responsible party
Sponsor
First posted
Jan 7, 2021
Start date
Jan 15, 2021
Primary completion
Jan 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
May 3, 2024

Study contacts

John D Gelles, OD
principal investigator · The Cornea and Laser Eye Institute

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion